A groundbreaking shift in our drug policy has happened, as the regulators permit the availability of psilocybin mushrooms recalled in Canada mushrooms for therapeutic purposes. Until now, these substances were strictly restricted, but a increasing body of evidence suggests they could offer aid for psychological illnesses like anxiety. This change r